code,desc,source
0037U,TRGT GEN SEQ DNA 324 GENES,Lab
0108U,GI BARRETT ESOPH 9 PRTN BMRK,Lab
0239U,TRGT GEN SEQ ALYS PNL 311+,Lab
0241U,NFCT DS VIR RESP RNA 4 TRGT,Lab
0242U,TRGT GEN SEQ ALYS PNL 55-74,Lab
0315U,ONC CUTAN SQ CLL CA MRNA 40,Lab
0326U,TRGT GEN SEQ ALYS PNL 83+,Lab
0340U,ONC PAN CA ALYS MRD PLASMA,Lab
0345U,PSYC GENOM ALYS PNL 15 GEN,Lab
11042,Dbrdmt subq tis 1st 20sqcm/<,CPT
11043,Dbrdmt musc&/fsca 1st 20/<,CPT
11056,Parng/cutg b9 hyprkr les 2-4,CPT
11102,Tangntl bx skin single les,CPT
11721,Debride nail 6 or more,CPT
12032,Intmd rpr s/a/t/ext 2.6-7.5,CPT
13132,Cmplx rpr f/c/c/m/n/ax/g/h/f,CPT
15823,Blepharp upr eyelid xcsv skn,CPT
17000,Destruct premalg lesion,CPT
17003,Destruct premalg les 2-14,CPT
17004,Destroy premal lesions 15/>,CPT
17110,Destruct b9 lesion 1-14,CPT
17311,Mohs 1 stage h/n/hf/g,CPT
17312,Mohs addl stage,CPT
17313,Mohs 1 stage t/a/l,CPT
20610,Drain/inj joint/bursa w/o us,CPT
20611,Drain/inj joint/bursa w/us,CPT
22612,Arthrd pst tq 1ntrspc lumbar,CPT
23472,Reconstruct shoulder joint,CPT
27130,Total hip arthroplasty,CPT
27245,Treat thigh fracture,CPT
27447,Total knee arthroplasty,CPT
29827,Sho arthrs srg rt8tr cuf rpr,CPT
31231,Nasal endoscopy dx,CPT
33285,Insj subq car rhythm mntr,CPT
33361,Replace aortic valve perq,CPT
33533,Cabg arterial single,CPT
36415,Coll venous bld venipuncture,CPT
36465,Njx noncmpnd sclrsnt 1 vein,CPT
36475,Endovenous rf 1st vein,CPT
36482,Endoven ther chem adhes 1st,CPT
36902,Intro cath dialysis circuit,CPT
37225,Fem/popl revas w/ather,CPT
37227,Fem/popl revasc stnt & ather,CPT
37229,Tib/per revasc w/ather,CPT
43239,Egd biopsy single/multiple,CPT
45378,Diagnostic colonoscopy,CPT
45380,Colonoscopy and biopsy,CPT
45385,Colonoscopy w/lesion removal,CPT
52000,Cystourethroscopy,CPT
62323,Njx interlaminar lmbr/sac,CPT
63047,Lam facetec & foramot lumbar,CPT
63650,Implant neuroelectrodes,CPT
63685,Ins/rplc spi npg/rcvr pocket,CPT
64483,Njx aa&/strd tfrm epi l/s 1,CPT
64493,Inj paravert f jnt l/s 1 lev,CPT
64561,Implant neuroelectrodes,CPT
64590,Ins/rpl prph sac/gstr npg/r,CPT
64635,Destroy lumb/sac facet jnt,CPT
64721,Carpal tunnel surgery,CPT
65778,Cover eye w/membrane,CPT
65820,Goniotomy,CPT
66821,After cataract laser surgery,CPT
66982,Xcapsl ctrc rmvl cplx wo ecp,CPT
66984,Xcapsl ctrc rmvl w/o ecp,CPT
66991,Xcapsl ctrc rmvl insj 1+,CPT
67028,Injection eye drug,CPT
70450,Ct head/brain w/o dye,CPT
70551,Mri brain stem w/o dye,CPT
70553,Mri brain stem w/o & w/dye,CPT
71045,X-ray exam chest 1 view,CPT
71046,X-ray exam chest 2 views,CPT
71250,Ct thorax dx c-,CPT
71260,Ct thorax dx c+,CPT
71275,Ct angiography chest,CPT
72125,Ct neck spine w/o dye,CPT
72148,Mri lumbar spine w/o dye,CPT
72197,Mri pelvis w/o & w/dye,CPT
73721,Mri jnt of lwr extre w/o dye,CPT
74176,Ct abd & pelvis w/o contrast,CPT
74177,Ct abd & pelvis w/contrast,CPT
74178,Ct abd&plv wo cntr flwd cntr,CPT
74183,Mri abd w/o cntr flwd cntr,CPT
76770,Us exam abdo back wall comp,CPT
77014,Ct scan for therapy guide,CPT
77063,Breast tomosynthesis bi,CPT
77067,Scr mammo bi incl cad,CPT
77280,Ther rad simulaj field smpl,CPT
77301,Radiotherapy dose plan imrt,CPT
77427,Radiation tx management x5,CPT
78431,Myocrd img pet rst&strs ct,CPT
78452,Ht muscle image spect mult,CPT
78492,Myocrd img pet mlt rst&strs,CPT
78815,Pet image w/ct skull-thigh,CPT
80048,METABOLIC PANEL TOTAL CA,Lab
80053,Comprehen metabolic panel,CPT
80061,Lipid panel,CPT
80307,Drug test prsmv chem anlyzr,CPT
81001,URINALYSIS AUTO W/SCOPE,Lab
81223,CFTR GENE FULL SEQUENCE,Lab
81238,F9 FULL GENE SEQUENCE,Lab
81249,G6PD FULL GENE SEQUENCE,Lab
81307,PALB2 GENE FULL GENE SEQ,Lab
81419,Epilepsy gen seq alys panel,CPT
81440,MITOCHONDRIAL GENE,Lab
81443,GENETIC TSTG SEVERE INH COND,Lab
81455,SO/HL 51/>GSAP DNA/DNA&RNA,Lab
81456,SO/HL 51/>GSAP RNA ALYS,Lab
81459,SO NEO GSAP DNA/DNA&RNA,Lab
81464,SO GSAP CLL FR MCRSTL INS,Lab
81479,Unlisted molecular pathology,CPT
81518,ONC BRST MRNA 11 GENES,Lab
81519,Oncology breast mrna,CPT
81528,Oncology colorectal scr,CPT
81529,ONC CUTAN MLNMA MRNA 31 GENE,Lab
81541,ONC PROSTATE MRNA 46 GENES,Lab
81542,Onc prostate mrna 22 cnt gen,CPT
81546,"ONC THYR MRNA 10,196 GEN ALG",Lab
81595,CARDIOLOGY HRT TRNSPL MRNA,Lab
82043,UR ALBUMIN QUANTITATIVE,Lab
82306,Vitamin d 25 hydroxy,CPT
82570,ASSAY OF URINE CREATININE,Lab
82607,VITAMIN B-12,Lab
82728,ASSAY OF FERRITIN,Lab
82746,ASSAY OF FOLIC ACID SERUM,Lab
82784,ASSAY IGA/IGD/IGG/IGM EACH,Lab
83036,Hemoglobin glycosylated a1c,CPT
83540,ASSAY OF IRON,Lab
83550,IRON BINDING TEST,Lab
83735,ASSAY OF MAGNESIUM,Lab
83880,ASSAY OF NATRIURETIC PEPTIDE,Lab
83970,Assay of parathormone,CPT
84153,ASSAY OF PSA TOTAL,Lab
84165,PROTEIN E-PHORESIS SERUM,Lab
84403,ASSAY OF TOTAL TESTOSTERONE,Lab
84439,ASSAY OF FREE THYROXINE,Lab
84443,Assay thyroid stim hormone,CPT
84481,FREE ASSAY (FT-3),Lab
85025,Complete cbc w/auto diff wbc,CPT
85027,COMPLETE CBC AUTOMATED,Lab
86235,NUCLEAR ANTIGEN ANTIBODY,Lab
86334,IMMUNOFIX E-PHORESIS SERUM,Lab
87086,URINE CULTURE/COLONY COUNT,Lab
87150,DNA/RNA AMPLIFIED PROBE,Lab
87186,MICROBE SUSCEPTIBLE MIC,Lab
87426,SARSCOV CORONAVIRUS AG IA,Lab
87428,SARSCOV & INF VIR A&B AG IA,Lab
87481,Candida dna amp probe,CPT
87500,VANOMYCIN DNA AMP PROBE,Lab
87502,INFLUENZA DNA AMP PROBE,Lab
87631,RESP VIRUS 3-5 TARGETS,Lab
87635,SARS-COV-2 COVID-19 AMP PRB,Lab
87636,SARSCOV2 & INF A&B AMP PRB,Lab
87637,SARSCOV2&INF A&B&RSV AMP PRB,Lab
87640,STAPH A DNA AMP PROBE,Lab
87651,STREP A DNA AMP PROBE,Lab
87653,STREP B DNA AMP PROBE,Lab
87798,Detect agent nos dna amp,CPT
87801,DETECT AGNT MULT DNA AMPLI,Lab
87804,INFLUENZA ASSAY W/OPTIC,Lab
87811,SARS-COV-2 COVID19 W/OPTIC,Lab
88112,CYTOPATH CELL ENHANCE TECH,Lab
88120,CYTP URNE 3-5 PROBES EA SPEC,Lab
88173,CYTOPATH EVAL FNA REPORT,Lab
88185,FLOWCYTOMETRY/TC ADD-ON,Lab
88189,FLOWCYTOMETRY/READ 16 & >,Lab
88305,Tissue exam by pathologist,CPT
88307,Tissue exam by pathologist,CPT
88309,TISSUE EXAM BY PATHOLOGIST,Lab
88312,Special stains group 1,CPT
88313,SPECIAL STAINS GROUP 2,Lab
88331,PATH CONSLTJ SURG 1 BLK 1SPC,Lab
88341,Imhchem/imcytchm ea add antb,CPT
88342,Imhchem/imcytchm 1st antb,CPT
88344,IMHCHEM/IMCYTCHM EA MLT ANTB,Lab
88360,TUMOR IMMUNOHISTOCHEM/MANUAL,Lab
88374,M/PHMTRC ALYS ISHQUANT/SEMIQ,Lab
88377,M/PHMTRC ALYS ISHQUANT/SEMIQ,Lab
90480,Admn sarscov2 vacc 1 dose,CPT
90653,Iiv adjuvant vaccine im,CPT
90662,Iiv no prsv increased ag im,CPT
90677,Pcv20 vaccine im,CPT
90791,Psych diagnostic evaluation,CPT
90792,Psych diag eval w/med srvcs,CPT
90832,Psytx w pt 30 minutes,CPT
90833,Psytx w pt w e/m 30 min,CPT
90834,Psytx w pt 45 minutes,CPT
90837,Psytx w pt 60 minutes,CPT
90960,Esrd srv 4 visits p mo 20+,CPT
90961,Esrd srv 2-3 vsts p mo 20+,CPT
90966,Esrd home pt serv p mo 20+,CPT
91320,Sarscv2 vac 30mcg trs-suc im,CPT
91322,Sarscov2 vac 50 mcg/0.5ml im,CPT
92004,Compre oph exam new pt 1/>,CPT
92012,Intrm oph exam est patient,CPT
92014,Compre oph exam est pt 1/>,CPT
92083,Extended visual field xm,CPT
92133,Cptrzd oph dx img pst sgm on,CPT
92134,Cptrz oph dx img pst sgm rta,CPT
92250,Fundus photography w/i&r,CPT
92928,Prq card stent w/angio 1 vsl,CPT
93000,Electrocardiogram complete,CPT
93010,Electrocardiogram report,CPT
93229,Remote 30 day ecg tech supp,CPT
93243,Ext ecg>48hr<7d scan a/r,CPT
93247,Ext ecg>7d<15d scan a/r,CPT
93298,Rem interrog dev eval scrms,CPT
93306,Tte w/doppler complete,CPT
93458,L hrt artery/ventricle angio,CPT
93656,Compre ep eval abltj atr fib,CPT
93880,Extracranial bilat study,CPT
93925,Lower extremity study,CPT
93970,Extremity study,CPT
93971,Extremity study,CPT
95165,Antigen therapy services,CPT
95251,CONT GLUC MNTR ANALYSIS I&R,Lab
95886,Musc test done w/n test comp,CPT
96365,Ther/proph/diag iv inf init,CPT
96372,Ther/proph/diag inj sc/im,CPT
96413,Chemo iv infusion 1 hr,CPT
97110,Therapeutic exercises,CPT
97112,Neuromuscular reeducation,CPT
97116,Gait training therapy,CPT
97140,Manual therapy 1/> regions,CPT
97161,Pt eval low complex 20 min,CPT
97162,Pt eval mod complex 30 min,CPT
97530,Therapeutic activities,CPT
97535,Self care mngment training,CPT
97610,Low frequency non-thermal us,CPT
98940,Chiropract manj 1-2 regions,CPT
98941,Chiropract manj 3-4 regions,CPT
99203,Office o/p new low 30 min,CPT
99204,Office o/p new mod 45 min,CPT
99205,Office o/p new hi 60 min,CPT
99212,Office o/p est sf 10 min,CPT
99213,Office o/p est low 20 min,CPT
99214,Office o/p est mod 30 min,CPT
99215,Office o/p est hi 40 min,CPT
99222,1st hosp ip/obs moderate 55,CPT
99223,1st hosp ip/obs high 75,CPT
99231,Sbsq hosp ip/obs sf/low 25,CPT
99232,Sbsq hosp ip/obs moderate 35,CPT
99233,Sbsq hosp ip/obs high 50,CPT
99238,Hosp ip/obs dschrg mgmt 30/<,CPT
99239,Hosp ip/obs dschrg mgmt >30,CPT
99284,Emergency dept visit mod mdm,CPT
99285,Emergency dept visit hi mdm,CPT
99291,Critical care first hour,CPT
99305,1st nf care moderate mdm 35,CPT
99306,1st nf care high mdm 50,CPT
99308,Sbsq nf care low mdm 20,CPT
99309,Sbsq nf care moderate mdm 30,CPT
99310,Sbsq nf care high mdm 45,CPT
99348,Home/res vst est low mdm 30,CPT
99349,Home/res vst est mod mdm 40,CPT
99350,Home/res vst est high mdm 60,CPT
99439,Chrnc care mgmt staf ea addl,CPT
99454,Rem mntr physiol param dev,CPT
99457,Rem physiol mntr 1st 20 min,CPT
99458,Rem physiol mntr ea addl 20,CPT
99487,Cplx chrnc care 1st 60 min,CPT
99489,Cplx chrnc care ea addl 30,CPT
99490,Chrnc care mgmt staff 1st 20,CPT
99495,Transj care mgmt mod f2f 14d,CPT
99496,Transj care mgmt high f2f 7d,CPT
99497,Advncd care plan 30 min,CPT
A0425,"Ground mileage, per statute mile Ground mileage 52 A C O1A D 02001010120010101 N",HCPCS
A0427,"Ambulance service, advanced life support, emergency transport, level 1 (als 1 - Als1-emergency 52 A C O1A D 02001010120010101 N",HCPCS
A0428,"Ambulance service, basic life support, non-emergency transport, (bls) Bls 52 A C O1A D 02001010120010101 N",HCPCS
A0429,"Ambulance service, basic life support, emergency transport (bls-emergency) Bls-emergency 52 A C O1A D 02001010120010101 N",HCPCS
A0435,"Fixed wing air mileage, per statute mile Fixed wing air mileage 52 A C O1A D 02001010120010101 N",HCPCS
A0436,"Rotary wing air mileage, per statute mile Rotary wing air mileage 52 A C O1A D 02001010120010101 N",HCPCS
A4225,"Supplies for external insulin infusion pump, syringe type cartridge, sterile, Sup/ext insulin inf pump syr34 A 60-14 D D1E P 02017010120170101 N",HCPCS
A4239,"Supply allowance for non-adjunctive, non-implanted continuous glucose monitor Non-adju cgm supply allow 34 A C D1E 9 02023010120230101 N",HCPCS
A4253,"Blood glucose test or reagent strips for home blood glucose monitor, per 50 Blood glucose/reagent strips32 A60-11 D D1E P 01986010119980701 N",HCPCS
A4332,"Lubricant, individual sterile packet, each Lube sterile packet 37 A 2130 D D1F P 02001010120050101 N",HCPCS
A4349,"Male external catheter, with or without adhesive, disposable, each Disposable male external cat37 A 2130 D D1A P 02005010120050101 N",HCPCS
A4351,"Intermittent urinary catheter; straight tip, with or without coating (teflon, Straight tip urine catheter 37 A 2130 D D1F P 01990010120020101 N",HCPCS
A4352,"Intermittent urinary catheter; coude (curved) tip, with or without coating Coude tip urinary catheter 37 A 2130 D D1F P 01990010120020101 N",HCPCS
A4353,"Intermittent urinary catheter, with insertion supplies Intermittent urinary cath 37 A 2130 D D1F P 01997010120030101 N",HCPCS
A4362,"Skin barrier; solid, 4 x 4 or equivalent; each Solid skin barrier 37 A 2130 D D1F P 01985010119900101 N",HCPCS
A4385,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in Ost skn barrier sld ext wear37 A 2130 D D1F P 02000010120030101 N",HCPCS
A4394,"Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid Ostomy pouch liq deodorant 37 A 2130 D D1F P 02000010120070101 N",HCPCS
A4407,"Ostomy skin barrier, with flange (solid, flexible, or accordion), extended Ext wear ost skn barr <=4sq""37 A 2130 D D1F P 02003010120030101 N",HCPCS
A4409,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, Ost skn barr convex <=4 sq i37 A 2130 D D1F P 02003010120060101 N",HCPCS
A4419,"Ostomy pouch, closed; for use on barrier with non-locking flange, with filter Ost pch for bar w flange/flt37 A C D1F P 02004010120040101 N",HCPCS
A4425,"Ostomy pouch, drainable; for use on barrier with non-locking flange, with Ost pch drain for barrier fl37 A C D1F P 02004010120040101 N",HCPCS
A4450,"Tape, non-waterproof, per 18 square inches Non-waterproof tape 37 A 2130 D D1F LP 02003010120030101 N",HCPCS
A4452,"Tape, waterproof, per 18 square inches Waterproof tape 37 A 2130 D D1F LP 02003010120030101 N",HCPCS
A4456,"Adhesive remover, wipes, any type, each Adhesive remover, wipes 37 A 2130 D D1F P 02010010120100101 N",HCPCS
A4604,Tubing with integrated heating element for use with positive airway pressure Tubing with heating element 32 A C D1E P 02006010120060101 N,HCPCS
A5057,"Ostomy pouch, drainable, with extended wear barrier attached, with built in 1 pc ost pou w built-in conv37 A 2130 D D1F P 02012010120120101 N",HCPCS
A5063,"Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each Drain ostomy pouch w/flange 37 A 2130 D D1F P 01990010120030101 N",HCPCS
A5120,"Skin barrier, wipes or swabs, each Skin barrier, wipe or swab 37 A 2130 D D1F P 02006010120060101 N",HCPCS
A6021,"Collagen dressing, sterile, size 16 sq. in. or less, each Collagen dressing <=16 sq in35 A 2079 D D1A S 02001010120130101 N",HCPCS
A6196,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. Alginate dressing <=16 sq in35 A 2079 D D1A S 01997010120090101 N",HCPCS
A6197,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more Alginate drsg >16 <=48 sq in35 A 2079 D D1A S 01997010120090101 N",HCPCS
A6216,"Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without Non-sterile gauze<=16 sq in 35 A 2079 D D1A S 01997010120030101 N",HCPCS
A6219,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size Gauze <= 16 sq in w/border 35 A 2079 D D1A S 01997010120090101 N",HCPCS
A6402,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive Sterile gauze <= 16 sq in 35 A 2079 D D1A LS 01997010120060101 N",HCPCS
A6446,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or Conform band s w>=3"" <5""/yd 35 A C D1A S 02004010120040101 N",HCPCS
A7031,"Face mask interface, replacement for full face mask, each Replacement facemask interfa32 A C D1E APR 02003010120030101 N",HCPCS
A7032,"Cushion for use on nasal mask interface, replacement only, each Replacement nasal cushion 32 A C D1E APR 02003010120060101 N",HCPCS
A7033,"Pillow for use on nasal cannula type interface, replacement only, pair Replacement nasal pillows 32 A C D1E APR 02003010120060101 N",HCPCS
A7034,Nasal interface (mask or cannula type) used with positive airway pressure Nasal application device 32 A C D1E APR 02003010120030101 N,HCPCS
A7035,Headgear used with positive airway pressure device Pos airway press headgear 32 A C D1E APR 02003010120030101 N,HCPCS
A7038,"Filter, disposable, used with positive airway pressure device Pos airway pressure filter 32 A C D1E APR 02003010120030101 N",HCPCS
A9575,"Injection, gadoterate meglumine, 0.1 ml Inj gadoterate meglumi 0.1ml57 A C I1E 4 02014010120140101 N",HCPCS
A9585,"Injection, gadobutrol, 0.1 ml Gadobutrol injection 57 A C I1E 4 02012010120120101 N",HCPCS
B4034,"Enteral feeding supply kit; syringe fed, per day, includes but not limited to Enter feed supkit syr by day39 A65-10 2130 4450 D O1C E 01986010120110101 N",HCPCS
B4035,"Enteral feeding supply kit; pump fed, per day, includes but not limited to Enteral feed supp pump per d39 A65-10 2130 4450 D O1C E 01986010120110101 N",HCPCS
B4149,"Enteral formula, manufactured blenderized natural foods with intact nutrients, Ef blenderized foods 39 A65-10 2130 4450 D O1C E 02005010120060101 N",HCPCS
B4150,"Enteral formula, nutritionally complete with intact nutrients, includes Ef complet w/intact nutrient39 A65-10 2130 4450 D O1C E 01986010120050101 N",HCPCS
B4152,"Enteral formula, nutritionally complete, calorically dense (equal to or greater Ef calorie dense>/=1.5kcal 39 A65-10 2130 4450 D O1C E 01984010120050101 N",HCPCS
B4153,"Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and Ef hydrolyzed/amino acids 39 A65-10 2130 4450 D O1C E 01986010120050101 N",HCPCS
B4154,"Enteral formula, nutritionally complete, for special metabolic needs, excludes Ef spec metabolic noninherit39 A65-10 2130 4450 D O1C E 01984010120050101 N",HCPCS
B4185,"Parenteral nutrition solution, not otherwise specified, 10 grams lipids Pn soln nos 10 grams lipids 39 A D 0126O1C E 02006010120200101 N",HCPCS
C9290,"Injection, bupivacaine liposome, 1 mg Inj, bupivacaine liposome 53 A 1833(t) D O1E 1 0201204012025010120241231D",HCPCS
E0431,"Portable gaseous oxygen system, rental; includes portable container, regulator, Portable gaseous 02 33 A60-4 4107.9 D D1C R 01993010120010101 N",HCPCS
E0601,Continuous positive airway pressure (cpap) device Cont airway pressure device 36 A60-17 D D1E R 01988010120140101 N,HCPCS
E1390,"Oxygen concentrator, single delivery port, capable of delivering 85 percent or Oxygen concentrator 33 A60-4 D D1C R 02000010120040101 N",HCPCS
G0008,Administration of influenza virus vaccine Admin influenza virus vac 54 A C O1G V 01994010119960101 N,HCPCS
G0103,PSA SCREENING,Lab
G0283,"Electrical stimulation (unattended), to one or more areas for indication(s) Elec stim other than wound 11 A C P5E 1UW 02003010120030101 N",HCPCS
G0416,"PROSTATE BIOPSY, ANY MTHD",Lab
G0439,"Annual wellness visit, includes a personalized prevention plan of service Ppps, subseq visit 13 A C M5D 1 02011010120110101 N",HCPCS
G0444,"Annual depression screening, 5 to 15 minutes Depression screen annual 13 A C Y1 1 02011101420230101 N",HCPCS
G0480,DRUG TEST DEF 1-7 CLASSES,Lab
G0481,DRUG TEST DEF 8-14 CLASSES,Lab
G0482,DRUG TEST DEF 15-21 CLASSES,Lab
G0483,DRUG TEST DEF 22+ CLASSES,Lab
G2211,Visit complexity inherent to evaluation and management associated with medical Complex e/m visit add on 00 9 C Z2 1 02021010120210101 N,HCPCS
J0129,"Injection, abatacept, 10 mg (code may be used for medicare when drug Abatacept injection 51 A CYY20080101 O1E 1P 02007010120120101 N",HCPCS
J0174,"Injection, lecanemab-irmb, 1 mg Inj, lecanemab-irmb, 1 mg 00 9 CYY20230706 O1E 1P 02023070620230706 N",HCPCS
J0178,"Injection, aflibercept, 1 mg Aflibercept injection 51 A CYY20130101 O1E 1P 02013010120130101 N",HCPCS
J0185,"Injection, aprepitant, 1 mg Inj., aprepitant, 1 mg 51 A CYY20190101 O1E 1 02019010120190101 N",HCPCS
J0256,"Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg Alpha 1 proteinase inhibitor51 A 2049 DYY20080101 O1E 1P 01989010120120101 N",HCPCS
J0461,"Injection, atropine sulfate, 0.01 mg Atropine sulfate injection 51 A 2049 D O1E 1P 02010010120100101 N",HCPCS
J0485,"Injection, belatacept, 1 mg Belatacept injection 51 A CYY20130101 O1E 1P 02013010120130101 N",HCPCS
J0491,"Injection, anifrolumab-fnia, 1 mg Inj anifrolumab-fnia 1mg 51 A CYY20220401 O1E 1P 02022040120220401 N",HCPCS
J0585,"Injection, onabotulinumtoxina, 1 unit Injection,onabotulinumtoxina51 A 2049 DYY20080101 O1E 1P 01991010120100101 N",HCPCS
J0588,"Injection, incobotulinumtoxin a, 1 unit Incobotulinumtoxin a 51 A CYY20120101 O1E 1P 02012010120120101 N",HCPCS
J0665,"Injection, bupivicaine, not otherwise specified, 0.5 mg Inj, bupivacaine, nos, 0.5mg51 A CYY20240101 O1E 1 02023070120240101 N",HCPCS
J0696,"Injection, ceftriaxone sodium, per 250 mg Ceftriaxone sodium injection51 A 2049 D O1E 1P 01990010119970101 N",HCPCS
J0702,"Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg Betamethasone acet&sod phosp51 A 2049 D O1E 1P 01995010120080101 N",HCPCS
J0717,"Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug Certolizumab pegol inj 1mg 51 A CYY20140101 O1E 1P 02014010120140101 N",HCPCS
J0872,"Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent Daptomycin (xellia) unrefrig51 A CYY20240701 O1E 1P 02024070120240701 N",HCPCS
J0878,"Injection, daptomycin, 1 mg Daptomycin injection 51 A C O1E 1P 02005010120240101 N",HCPCS
J0881,"Injection, darbepoetin alfa, 1 microgram (non-esrd use) Darbepoetin alfa, non-esrd 51 A DYY20080101 0132O1E 1L 02006010120060101 N",HCPCS
J0885,"Injection, epoetin alfa, (for non-esrd use), 1000 units Epoetin alfa, non-esrd 51 A 2049 DYY20080101 O1E 9 02006010120060101 N",HCPCS
J0896,"Injection, luspatercept-aamt, 0.25 mg Inj luspatercept-aamt 0.25mg51 A CYY20200701 O1E 1 02020070120200701 N",HCPCS
J0897,"Injection, denosumab, 1 mg Denosumab injection 51 A CYY20120101 O1E 1P 02012010120120101 N",HCPCS
J1010,"Injection, methylprednisolone acetate, 1 mg Inj, methylpred acetate 1 mg51 A 2049 D O1E 1P 02024040120240401 N",HCPCS
J1071,"Injection, testosterone cypionate, 1 mg Inj testosterone cypionate 51 A D 0194O1E 1P 02015010120150101 N",HCPCS
J1100,"Injection, dexamethasone sodium phosphate, 1 mg Dexamethasone sodium phos 51 A 2049 D O1E 1P 01982010120010101 N",HCPCS
J1306,"Injection, inclisiran, 1 mg Injection, inclisiran, 1 mg 51 A CYY20220701 O1E 1 02022070120220701 N",HCPCS
J1437,"Injection, ferric derisomaltose, 10 mg Inj. fe derisomaltose 10 mg 51 A C O1E 1P 02020100120230101 N",HCPCS
J1439,"Injection, ferric carboxymaltose, 1 mg Inj ferric carboxymaltos 1mg51 A CYY20150101 O1E 1P 02015010120150101 N",HCPCS
J1442,"Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram Inj filgrastim excl biosimil51 A DYY20140101 0187O1E 1P 02014010120160101 N",HCPCS
J1448,"Injection, trilaciclib, 1mg Injection, trilaciclib, 1mg 51 A CYY20211001 O1E 1P 02021100120211001 N",HCPCS
J1449,"Injection, eflapegrastim-xnst, 0.1 mg Inj eflapegrastim-xnst 0.1mg51 A CYY20230401 O1E 1P 02023040120230401 N",HCPCS
J1453,"Injection, fosaprepitant, 1 mg Fosaprepitant injection 51 A C O1E 1P 02009010120220101 N",HCPCS
J1555,"Injection, immune globulin (cuvitru), 100 mg Inj cuvitru, 100 mg 51 A CYY20180101 D1G 1P 02018010120180101 N",HCPCS
J1558,"Injection, immune globulin (xembify), 100 mg Inj. xembify, 100 mg 51 A CYY20200701 O1E 1P 02020070120200701 N",HCPCS
J1559,"Injection, immune globulin (hizentra), 100 mg Hizentra injection 51 A CYY20110101 O1E 1P 02011010120110101 N",HCPCS
J1561,"Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., Gamunex-c/gammaked 51 A 2049 DYY20080101 O1E 1P 02008010120130101 N",HCPCS
J1568,"Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., Octagam injection 51 A CYY20080101 O1E 1P 02008010120080101 N",HCPCS
J1569,"Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., Gammagard liquid injection 51 A 2049 DYY20080101 O1E 1P 02008010120130101 N",HCPCS
J1575,"Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin Hyqvia 100mg immuneglobulin 51 A CYY20160101 O1E 1P 02016010120160101 N",HCPCS
J1602,"Injection, golimumab, 1 mg, for intravenous use Golimumab for iv use 1mg 51 A CYY20140101 O1E 1P 02014010120140101 N",HCPCS
J1745,"Injection, infliximab, excludes biosimilar, 10 mg Infliximab not biosimil 10mg51 A 2049 DYY20080101 O1E 1P 02000010120170101 N",HCPCS
J1756,"Injection, iron sucrose, 1 mg Iron sucrose injection 51 A C O1E 1P 02003010120030101 N",HCPCS
J1817,"Insulin for administration through dme (i.e., insulin pump) per 50 units Insulin for insulin pump use51 A C D1G 1P 02003010120030101 N",HCPCS
J1930,"Injection, lanreotide, 1 mg Lanreotide injection 51 A CYY20150101 O1E 1P 02009010120090101 N",HCPCS
J2182,"Injection, mepolizumab, 1 mg Injection, mepolizumab, 1mg 51 A CYY20170101 O1E 1 02017010120170101 N",HCPCS
J2323,"Injection, natalizumab, 1 mg Natalizumab injection 51 A CYY20080101 O1E 1P 02008010120080101 N",HCPCS
J2327,"Injection, risankizumab-rzaa, intravenous, 1 mg Inj risankizumab-rzaa 1 mg 51 A CYY20230101 O1E 1P 02023010120230101 N",HCPCS
J2350,"Injection, ocrelizumab, 1 mg Injection, ocrelizumab, 1 mg51 A CYY20180101 O1E 1P 02018010120180101 N",HCPCS
J2356,"Injection, tezepelumab-ekko, 1 mg Inj tezepelumab-ekko, 1mg 51 A CYY20220701 O1E 1 02022070120220701 N",HCPCS
J2357,"Injection, omalizumab, 5 mg Omalizumab injection 51 A CYY20080101 O1E 1P 02005010120050101 N",HCPCS
J2403,"Chloroprocaine hcl ophthalmic, 3% gel, 1 mg Chloroprocaine opht gel, 1mg51 A CYY20230401 O1E 1 02023040120230401 N",HCPCS
J2469,"Injection, palonosetron hcl, 25 mcg Palonosetron hcl 51 A C O1E 1P 02005010120240101 N",HCPCS
J2777,"Injection, faricimab-svoa, 0.1 mg Inj, faricimab-svoa, 0.1mg 51 A CYY20221001 O1E 1 02022100120221001 N",HCPCS
J2781,"Injection, pegcetacoplan, intravitreal, 1 mg Inj, pegcetacoplan, 1mg 51 A CYY20231001 O1E 1 02023100120231001 N",HCPCS
J2785,"Injection, regadenoson, 0.1 mg Regadenoson injection 51 A C O1E 1P 02009010120140101 N",HCPCS
J2919,"Injection, methylprednisolone sodium succinate, 5 mg Inj, methylpred sod succ 5mg51 A 2049 D O1E 1G 02024040120240401 N",HCPCS
J3032,"Injection, eptinezumab-jjmr, 1 mg Inj. eptinezumab-jjmr 1 mg 51 A CYY20201001 O1E 1P 02020100120201001 N",HCPCS
J3111,"Injection, romosozumab-aqqg, 1 mg Inj. romosozumab-aqqg 1 mg 51 A CYY20191001 0120O1E 1 02019100120191001 N",HCPCS
J3145,"Injection, testosterone undecanoate, 1 mg Testosterone undecanoate 1mg51 A DYY20150101 0127O1E 1 02015010120150101 N",HCPCS
J3245,"Injection, tildrakizumab, 1 mg Inj., tildrakizumab, 1 mg 51 A C O1E 1P 02019010120190101 N",HCPCS
J3247,"Injection, secukinumab, intravenous, 1 mg Inj secukinumab intrav 1mg 51 A CYY20240701 O1E 1P 02024070120240701 N",HCPCS
J3262,"Injection, tocilizumab, 1 mg Tocilizumab injection 51 A CYY20110101 O1E 1P 02011010120110101 N",HCPCS
J3285,"Injection, treprostinil, 1 mg Treprostinil injection 51 A CYY20080101 O1E 1P 02006010120060101 N",HCPCS
J3301,"Injection, triamcinolone acetonide, not otherwise specified, 10 mg Triamcinolone acet inj nos 51 A 2049 D O1E 1P 01991010120090101 N",HCPCS
J3304,"Injection, triamcinolone acetonide, preservative-free, extended-release, Inj triamcinolone ace xr 1mg51 A DYY20190101 0127O1E 1P 02019010120190101 N",HCPCS
J3380,"Injection, vedolizumab, intravenous, 1 mg Inj vedolizumab iv 1 mg 51 A DYY20160101 0127O1E 1P 02016010120240401 N",HCPCS
J7170,"Injection, emicizumab-kxwh, 0.5 mg Inj., emicizumab-kxwh 0.5 mg51 A CYY20190101 O1E 1 02019010120190101 N",HCPCS
J7179,"Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco Vonvendi inj 1 iu vwf:rco 51 A DYY20170101 0211O1E 1 02017010120170101 N",HCPCS
J7185,"Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. Xyntha inj 51 A CYY20100101 O1E 1P 02010010120100101 N",HCPCS
J7187,"Injection, von willebrand factor complex (humate-p), per iu vwf:rco Humate-p, inj 51 A 2049 DYY20080101 O1E 1P 02007010120080101 N",HCPCS
J7189,"Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram Factor viia recomb novoseven51 A 2049 DYY20080101 O1E 1P 02006010120210101 N",HCPCS
J7190,"Factor viii (antihemophilic factor, human) per i.u. Factor viii 51 A 2049 DYY20080101 O1E 1P 01986010119990101 N",HCPCS
J7192,"Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise Factor viii recombinant nos 51 A 2049 DYY20080101 O1E 1P 01994010120100101 N",HCPCS
J7195,"Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise Factor ix recombinant nos 51 A 2049 DYY20080101 O1E 1P 02002010120150101 N",HCPCS
J7200,"Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu Factor ix recombinan rixubis51 A 2049 DYY20150101 O1E 1P 02015010120150101 N",HCPCS
J7201,"Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. Factor ix alprolix recomb 51 A 2049 DYY20150101 O1E 1P 02015010120170101 N",HCPCS
J7202,"Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. Factor ix idelvion inj 51 A DYY20170101 0211O1E 1 02017010120170101 N",HCPCS
J7205,"Injection, factor viii fc fusion protein (recombinant), per iu Factor viii fc fusion recomb51 A DYY20160101 0127O1E 1P 02016010120160101 N",HCPCS
J7207,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. Factor viii pegylated recomb51 A DYY20170101 0127O1E 1 02017010120170101 N",HCPCS
J7208,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, Inj. jivi 1 iu 51 A DYY20190701 0127O1E 1 02019070120190701 N",HCPCS
J7209,"Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. Factor viii nuwiq recomb 1iu51 A CYY20170101 O1E 1 02017010120170101 N",HCPCS
J7211,"Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.Inj, kovaltry, 1 i.u. 51 A CYY20180101 O1E 1 02018010120180101 N",HCPCS
J7214,"Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), Altuviiio per factor viii iu51 A CYY20231001 O1E 1 02023100120231001 N",HCPCS
J7318,"Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg Inj, durolane 1 mg 51 A CYY20190101 O1E 1 02019010120190101 N",HCPCS
J7320,"Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg Genvisc 850, inj, 1mg 51 A CYY20180101 O1E 1 02017010120180101 N",HCPCS
J7325,"Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular Synvisc or synvisc-one 51 A CYY20100101 O1E 1 02010010120170101 N",HCPCS
J7328,"Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg Gelsyn-3 injection 0.1 mg 51 A CYY20180101 O1E 1 02016010120180101 N",HCPCS
J7329,"Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg Inj, trivisc 1 mg 51 A CYY20190101 O1E 1 02019010120190101 N",HCPCS
J7336,"Capsaicin 8% patch, per square centimeter Capsaicin 8% patch 51 A CYY20150101 O1E 9 02015010120150101 N",HCPCS
J7345,"Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg Aminolevulinic acid, 10% gel51 A DYY20180101 0213O1E 1 02018010120180101 N",HCPCS
J7503,"Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg Tacrol envarsus ex rel oral 51 A 2049.5 D O1E 1G 02016010120190101 N",HCPCS
J7507,"Tacrolimus, immediate release, oral, 1 mg Tacrolimus imme rel oral 1mg51 A 2049.5 D O1E 1G 01995010120140101 N",HCPCS
J7508,"Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg Tacrol astagraf ex rel oral 51 A 2049.5 D O1E 1G 02014010120180101 N",HCPCS
J7512,"Prednisone, immediate release or delayed release, oral, 1 mg Prednisone ir or dr oral 1mg51 A 2049.5 D O1E 1G 02016010120160101 N",HCPCS
J7515,"Cyclosporine, oral, 25 mg Cyclosporine oral 25 mg 51 A C O1E 1G 02000010120000101 N",HCPCS
J7517,"Mycophenolate mofetil, oral, 250 mg Mycophenolate mofetil oral 51 A C O1E 1G 02000010120000101 N",HCPCS
J7518,"Mycophenolic acid, oral, 180 mg Mycophenolic acid 51 A 2050.5 4471 5249 D O1E 1G 02005010120050101 N",HCPCS
J7520,"Sirolimus, oral, 1 mg Sirolimus, oral 51 A 2049.5 D O1E 1G 02001010120010101 N",HCPCS
J7527,"Everolimus, oral, 0.25 mg Oral everolimus 51 A 2049.5 D O1G 1G 02013010120140101 N",HCPCS
J7605,"Arformoterol, inhalation solution, fda approved final product, non-compounded, Arformoterol non-comp unit 51 A C D1G 1P 02008010120080101 N",HCPCS
J7606,"Formoterol fumarate, inhalation solution, fda approved final product, Formoterol fumarate, inh 51 A C D1G 1P 02009010120090101 N",HCPCS
J7613,"Albuterol, inhalation solution, fda-approved final product, non-compounded, Albuterol non-comp unit 00 9 2100.5 D D1G 1P 02005010120090701 N",HCPCS
J7614,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded, Levalbuterol non-comp unit 00 9 2100.5 D D1G 1P 02005010120090701 N",HCPCS
J7620,"Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved Albuterol ipratrop non-comp 51 A D 0135D1G 1P 02006010120070101 N",HCPCS
J7626,"Budesonide, inhalation solution, fda-approved final product, non-compounded, Budesonide non-comp unit 51 A C D1G 1P 02002010120070101 N",HCPCS
J7644,"Ipratropium bromide, inhalation solution, fda-approved final product, Ipratropium bromide non-comp51 A D 0135D1G 1P 02000010120070101 N",HCPCS
J7677,"Revefenacin inhalation solution, fda-approved final product, non-compounded, Revefenacin inh non-com 1mcg51 A C D1G 1P 02019070120190701 N",HCPCS
J9022,"Injection, atezolizumab, 10 mg Inj, atezolizumab,10 mg 51 A CYY20180101 O1D 1P 02018010120180101 N",HCPCS
J9025,"Injection, azacitidine, 1 mg Azacitidine injection 51 A C O1D 1P 02006010120230101 N",HCPCS
J9030,"Bcg live intravesical instillation, 1 mg Bcg live intravesical 1mg 51 A 2049 D O1D 1P 02019070120240101 N",HCPCS
J9041,"Injection, bortezomib, 0.1 mg Injection, bortezomib, 0.1mg51 A CYY20080101 O1D 1P 02005010120230101 N",HCPCS
J9047,"Injection, carfilzomib, 1 mg Injection, carfilzomib, 1 mg51 A CYY20140101 O1D 1P 02014010120140101 N",HCPCS
J9073,"Injection, cyclophosphamide (ingenus), 5 mg Inj cyclophosphamd (ingenus)51 A 2049 DYY20240401 O1D 1P 02024040120240401 N, Inj cyclophos dr reddys 5 mg",HCPCS
J9119,"Injection, cemiplimab-rwlc, 1 mg Inj., cemiplimab-rwlc, 1 mg 51 A CYY20191001 O1D 1 02019100120191001 N",HCPCS
J9144,"Injection, daratumumab, 10 mg and hyaluronidase-fihj Daratumumab, hyaluronidase 51 A CYY20210101 O1D 1 02021010120210101 N",HCPCS
J9155,"Injection, degarelix, 1 mg Degarelix injection 51 A CYY20100101 O1E 1P 02010010120100101 N",HCPCS
J9171,"Injection, docetaxel, 1 mg Docetaxel injection 51 A 2049 D O1E 1P 02010010120240101 N",HCPCS
J9173,"Injection, durvalumab, 10 mg Inj., durvalumab, 10 mg 51 A CYY20190101 O1E 1 02019010120190101 N",HCPCS
J9176,"Injection, elotuzumab, 1 mg Injection, elotuzumab, 1mg 51 A CYY20170101 O1E 1 02017010120170101 N",HCPCS
J9177,"Injection, enfortumab vedotin-ejfv, 0.25 mg Inj enfort vedo-ejfv 0.25mg 51 A CYY20200701 O1E 1P 02020070120200701 N",HCPCS
J9263,"Injection, oxaliplatin, 0.5 mg Oxaliplatin 51 A C O1D 1P 02004010120180101 N",HCPCS
J9264,"Injection, paclitaxel protein-bound particles, 1 mg Paclitaxel protein bound 51 A CYY20080101 O1E 1P 02006010120070101 N",HCPCS
J9267,"Injection, paclitaxel, 1 mg Paclitaxel injection 51 A D 0194O1D 1P 02015010120150101 N",HCPCS
J9271,"Injection, pembrolizumab, 1 mg Inj pembrolizumab 51 A CYY20160101 O1D 1P 02016010120160101 N",HCPCS
J9299,"Injection, nivolumab, 1 mg Injection, nivolumab 51 A DYY20160101 0127O1D 1P 02016010120160101 N",HCPCS
J9306,"Injection, pertuzumab, 1 mg Injection, pertuzumab, 1 mg 51 A CYY20140101 O1D 1 02014010120140101 N",HCPCS
J9312,"Injection, rituximab, 10 mg Inj., rituximab, 10 mg 51 A 2049 DYY20190101 O1D 1P 02019010120190101 N",HCPCS
J9317,"Injection, sacituzumab govitecan-hziy, 2.5 mg Sacituzumab govitecan-hziy 51 A CYY20210101 O1D 1P 02021010120210101 N",HCPCS
J9332,"Injection, efgartigimod alfa-fcab, 2mg Inj efgartigimod 2mg 51 A CYY20220701 O1D 1 02022070120220701 N",HCPCS
J9334,"Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc Inj efgart-alfa 2mg hya-qvfc51 A CYY20240101 O1D 1P 02024010120240101 N",HCPCS
J9358,"Injection, fam-trastuzumab deruxtecan-nxki, 1 mg Inj fam-trastu deru-nxki 1mg51 A CYY20200701 O1E 1P 02020070120200701 N",HCPCS
P9603,Travel allowance one way in connection with medically necessary laboratory One-way allow prorated miles22 A 51141K D 0039Y2 5 01987010119920101 N,HCPCS
Q0138,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd Ferumoxytol, non-esrd 51 A CYY20100101 O1E 1P 02010010120100101 N",HCPCS
Q5101,"Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram Injection, zarxio 51 A DYY20240101 0187O1E 1P 02015070120240101 N",HCPCS
Q5106,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 Inj retacrit non-esrd use 51 A 2049 DYY20180701 O1E 9 02018070120200101 N",HCPCS
Q5110,"Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram Nivestym 51 A 2049 DYY20181001 O1E 1P 02018100120181001 N",HCPCS
Q5125,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram Inj, releuko 1 mcg 51 A CYY20221001 O1E 1 02022100120221001 N",HCPCS
Q9965,"Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml Locm 100-199mg/ml iodine,1ml51 A 15022 D I1E 4 02008010120080101 N",HCPCS
Q9966,"Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Locm 200-299mg/ml iodine,1ml51 A 15022 D I1E 4 02008010120080101 N",HCPCS
Q9967,"Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Locm 300-399mg/ml iodine,1ml51 A 15022 D I1E 4 02008010120080101 N",HCPCS
